ASP Isotopes discloses 15.1% stake in ENDRA ahead of merger vote

ASP Isotopes Inc. disclosed a 15.1% beneficial stake in ENDRA Life Sciences Inc.’s common stock and said it plans to vote on a merger at ENDRA’s special shareholder meeting, citing recent purchases and warrants that increase its voting power.